ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

Dinner To Raise Funds For NIH Children’s Inn

March 31, 1989

In Brief: appropriations Approved; Grants, contracts May Flow Unimpeded; NCI Positions An Issue

December 16, 1977

Nine contracts For Automated Pap Test Systems Total $1.7 Million

October 18, 1974

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

Also STAR trial can be completed with fewer women than planned, NSABP says.

November 7, 2003

Biomarker Test Outperforms PSA and Gleason Score in Study

July 26, 2013